Ventus Therapeutics: Funding, Investors & Team (Sep 2026)
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.
Ventus Therapeutics has raised $240M across 2 funding rounds on record, the most recent a Series C of $140M announced in Feb 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ventus Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2022.
Ventus Therapeutics Funding Rounds
Ventus Therapeutics raised $100M in a Series B announced in Apr 2021.
10 months later, a Series C of $140M was announced in Feb 2022.
Ventus Therapeutics Founders and Leadership Team
Contact details for the Ventus Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Ventus Therapeutics Funding Compared to Other Biotechnology Startups
Ventus Therapeutics' latest round of $140M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ventus Therapeutics in Biotechnology and Waltham
Companies Similar to Ventus Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Ventus Therapeutics Funding FAQs
What does Ventus Therapeutics do?
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.
How much funding has Ventus Therapeutics raised?
Ventus Therapeutics has raised $240M across 2 rounds on record. The most recent is a Series C of $140M announced in Feb 2022.
When did Ventus Therapeutics last raise funding?
Ventus Therapeutics' most recent funding round on record is a Series C of $140M, announced in Feb 2022.
Who is the CEO of Ventus Therapeutics?
Marcelo Bigal is listed as CEO at Ventus Therapeutics.
Where is Ventus Therapeutics headquartered?
Ventus Therapeutics is based in Waltham, Massachusetts, United States.
How many employees does Ventus Therapeutics have?
Ventus Therapeutics is in the 51-100 employee band.
How does Ventus Therapeutics' funding compare to other Biotechnology startups?
Ventus Therapeutics' latest round of $140M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Ventus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ventus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.